跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 305 条关于
“SNCA”
全部
305
临床试验
196
药物
57
机构
4
资讯
48
去年
Arrowhead Pharmaceuticals Secures $200 Million Novartis Deal for Alpha-Synuclein siRNA Therapy
上个月
Shape Therapeutics Secures MJFF Grant to Advance SHP-201, a One-Time RNA-Editing Gene Therapy for Parkinson's Disease
7个月前
RNA Interference Therapy Market Expands with 90+ Drugs in Development Across 40+ Companies
8个月前
Arrowhead Pharmaceuticals Reports Strong Q1 2026 Results with REDEMPLO Launch Success and Promising Obesity Pipeline Data
3个月前
Genetics of Parkinson Disease: Paradigm Shifts and Future Prospects
9个月前
Gut-Brain Axis Emerges as Key Pathway in Parkinson's Disease Pathogenesis
去年
Arrowhead Pharmaceuticals' FDA Acceptance of Plozasiran NDA Marks Milestone in RNAi Therapeutics
去年
FDA Approves Simplified Dosing Regimen for Acetadote in Acetaminophen Overdose
去年
FDA Issues Complete Response Letter for Astellas' Izervay sNDA
去年
FDA Issues Complete Response Letter for Astellas' IZERVAY sNDA
第 1 页,共 5 页
上一页
下一页